Bouchet CA, McPherson KB, Coutens B, Janowsky A, Ingram SL. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation. J Neurosci. 2023 Jul 26;43(30):5458-5467. PubMed PMID: 37414560
McPherson KB, Bouchet CA, Coutens B, Ingram SL. Persistent inflammation selectively activates opioid-sensitive phasic-firing neurons within the vlPAG. J Neurophysiol. 2023 May 1;129(5):1237-1248. PubMed PMID: 37073984
Clyburn C, Li MH, Ingram SL, Andresen MC, Habecker BA. Cholinergic collaterals arising from noradrenergic sympathetic neurons in mice. J Physiol. 2023 Apr;601(7):1247-1264. PubMed PMID: 36797985
Coutens B, Ingram SL. Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics. Neuropharmacology. 2023 Mar 15;226:109408. PubMed PMID: 36584882
Sanchez G, Jutkiewicz EM, Ingram SL, Smrcka AV. Coincident Regulation of PLCß Signaling by Gq-Coupled and µOpioid Receptors Opposes Opioid- Mediated Antinociception. Mol Pharmacol. 2022 Sep 18. [Epub ahead of print] PubMed PMID: 36116788
McPherson KB, Ingram SL. Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway. Front Syst Neurosci. 2022;16:963812. PubMed PMID: 36045708
Ingram SL. Toward understanding the opioid paradox: cellular mechanisms of opioid-induced hyperalgesia. Neuropsychopharmacology. 2022 Jan;47(2):427-428. PubMed PMID: 34732843
McPherson KB, Ingram SL. Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway. Front Syst Neurosci. 2022;16:963812. PubMed PMID: 36045708